Business Wire

MA-BENU-NETWORKS

13.8.2019 13:37:10 CEST | Business Wire | Press release

Share
Benu Networks Releases Hyperscale Virtual Broadband Network Gateway to Its Leading Software-Defined Edge Platform

Benu Networks , the leading software and solutions provider simplifying the industry’s most complex edge networks, announced the launch of its new virtual broadband network gateway (vBNG ). This new network function builds upon Benu Networks’ Software-Defined Edge (SD-Edge) Platform, which features a set of rich, virtualized functionalities that enable service providers to instantly cloudify their network, rapidly create and deliver new services, and easily scale network performance.

Modern consumer expectation and demand, particularly from the lens of a managed service provider, is constantly shifting. Buying behavior and criteria have drastically changed - gone are the days when triple play deals created great value to consumers and helped drive ARPU growth for service providers. Nowadays, residential subscribers are moving to single play broadband access, which adds pressure for managed service providers to create customized, cutting-edge offerings that continue to impress consumers. However, this level of agility has proved difficult to achieve for most MSPs, who still depend on hardware to manage subscriber sessions, authentication, and more. Plus, the need to reduce operational and capital expenses in the midst of margin erosion adds an additional layer of complexity for MSPs to manage.

“Our network has relied on Benu Networks’ software for 4 years, on dedicated appliances. We’re thrilled to see the addition of a vBNG to their platform,” said Khetan Gajjar, CTO of VAST Networks. “One of the key challenges we face, particularly as Africa’s leading Wi-Fi provider of services, is our ability to be agile and dynamic with the services we offer and scaling these efficiently while retaining our standard of performance. We currently do this with the SD-Edge Platform to millions of users. Now, with the Benu vBNG, we won’t have to think too hard about the scaling required to tailor services to each customer and building out new offerings and scaling to tens and hundreds of millions of users. A vBNG also allows us to deliver network scale much closer to the edge and allows us to expand into markets much more cost-effectively.”

The vBNG, running on the Benu SD-Edge Platform, helps service providers achieve this vision by streamlining packet processing as well as separating the control plane and data plane for dynamic scaling, added agility, optimal network performance, and cost reduction. The flexible, open architecture supports 3rd party service stitching on top of the breadth of functionality native to the vBNG. Service providers can now consolidate functions such as TDF/DPI, CGNAT, SG, and BNG, into a single virtualized platform for ultra-low latency and high performance. With the Benu Networks vBNG, service providers can go beyond just providing a ‘dumb pipe’ broadband connection and instead rapidly provision value-added services that reduce churn and increase ARPU.

“Releasing our vBNG as a part of the Benu SD-Edge Platform furthers our mission to simplify edge applications, “ said Mads Lillelund, CEO of Benu Networks. “We’re looking to drastically simplify network transformation and make it easy for service providers to be more agile and innovative without locking them into one vendor. With our vBNG, we’ve taken a massive step toward achieving this goal.”

The vBNG virtualizes integral network functionality, empowering service providers to seamlessly transition to a cloud-based 5G ready network. Benu Networks’ technology simplifies the complexity of network optimization, helping service providers rapidly scale their offerings, manage their network, and ensure the service experience. By disaggregating legacy network structures and eliminating hardware dependencies, service providers are free to move towards a modern network, reduce costs, and improve customer experience.

To schedule a demo, visit https://benunetworks.com/contact-us/ .

About Benu Networks:

Benu Networks is a leading software and solutions provider, simplifying the industry’s most complex edge networks. With a comprehensive set of products and innovative solutions coupled with over a decade in the industry, Benu Networks delivers solutions to instantly transform legacy access networks, elastically manage services, and carve the path to 5G. For more information, please visit the Benu Networks’ website: www.benunetworks.com . Follow us on Twitter @benunets.

Link:

ClickThru

Social Media:

https://www.facebook.com/benunetworks/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 01:35:00 CEST | Press release

~ Creating Climate Solutions and New Market Opportunities through Source-Specific CO2 Emission and Uptake Monitoring via Satellite Constellation and Aircraft ~ Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Cap

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye